ZBIO · Zenas BioPharma, Inc.

$32.31 -0.01 (-0.03%)

Russell 2000 member Rebalance outlook locked

Market Cap

$2.06B

65.18M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed	Type	Industry	Offering	Sold	Min. Invest.	Investors	Exemptions
2024-05-14	New	Biotechnology	$200,145,732	$200,145,732	—	26	06b
2022-11-15	New	Biotechnology	$183,898,435	$183,898,435	—	17	06b

Showing 1–2 of 2 filings

Key facts CIK 1953926 CUSIP 98937L105 13F (30d) 136 filings 131 filers Visit website Investor relations